SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:hh-48893"
 

Search: onr:"swepub:oai:DiVA.org:hh-48893" > Animal Models of Rh...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Tuncel, J.Harvard Medical School, Boston, Massachusetts, United States of America; Karolinska Institutet, Stockholm, Sweden (author)

Animal Models of Rheumatoid Arthritis (I) : Pristane-Induced Arthritis in the Rat

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • 2016-05-26
  • Public Library of Science (PLoS),2016
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:hh-48893
  • https://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-48893URI
  • https://doi.org/10.1371/journal.pone.0155936DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:133685384URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-48402URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND: To facilitate the development of therapies for rheumatoid arthritis (RA), the Innovative Medicines Initiative BTCure has combined the experience from several laboratories worldwide to establish a series of protocols for different animal models of arthritis that reflect the pathogenesis of RA. Here, we describe chronic pristane-induced arthritis (PIA) model in DA rats, and provide detailed instructions to set up and evaluate the model and for reporting data. METHODS: We optimized dose of pristane and immunization procedures and determined the effect of age, gender, and housing conditions. We further assessed cage-effects, reproducibility, and frequency of chronic arthritis, disease markers, and efficacy of standard and novel therapies. RESULTS: Out of 271 rats, 99.6% developed arthritis after pristane-administration. Mean values for day of onset, day of maximum arthritis severity and maximum clinical scores were 11.8+/-2.0 days, 20.3+/-5.1 days and 34.2+/-11 points on a 60-point scale, respectively. The mean frequency of chronic arthritis was 86% but approached 100% in long-term experiments over 110 days. Pristane was arthritogenic even at 5 microliters dose but needed to be administrated intradermally to induce robust disease with minimal variation. The development of arthritis was age-dependent but independent of gender and whether the rats were housed in conventional or barrier facilities. PIA correlated well with weight loss and acute phase reactants, and was ameliorated by etanercept, dexamethasone, cyclosporine A and fingolimod treatment. CONCLUSIONS: PIA has high incidence and excellent reproducibility. The chronic relapsing-remitting disease and limited systemic manifestations make it more suitable than adjuvant arthritis for long-term studies of joint-inflammation and screening and validation of new therapeutics.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Haag, S.Karolinska Institutet, Stockholm, Sweden (author)
  • Hoffmann, M. H.University of Erlangen-Nuremberg, Erlangen, Germany; Medical University of Vienna, Vienna, Austria,Redoxis AB, Medicon Village, Lund, Sweden (author)
  • Yau, A. C.Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden (author)
  • Hultqvist, M.Redoxis AB, Medicon Village, Lund, Sweden (author)
  • Olofsson, P.Redoxis AB, Medicon Village, Lund, Sweden (author)
  • Bäcklund, J.Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden (author)
  • Nandakumar, Kutty Selva,1965-Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden(Swepub:hh)kutnam (author)
  • Weidner, D.University of Erlangen-Nuremberg, Erlangen, Germany (author)
  • Fischer, A.Medical University of Vienna, Vienna, Austria (author)
  • Leichsenring, A.Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany (author)
  • Lange, F.Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany (author)
  • Haase, C.Novo Nordisk A/S, Malov, Denmark (author)
  • Lu, S.Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, PR China (author)
  • Gulko, P. S.Icahn School of Medicine at Mount Sinai, New York, New York, United States of America,Medical University of Vienna, Vienna, Austria (author)
  • Steiner, G.Medical University of Vienna, Vienna, Austria (author)
  • Holmdahl, R.Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden (author)
  • Harvard Medical School, Boston, Massachusetts, United States of America; Karolinska Institutet, Stockholm, SwedenKarolinska Institutet, Stockholm, Sweden (creator_code:org_t)

Related titles

  • In:PLOS ONE: Public Library of Science (PLoS)11:51932-6203

Internet link

Find in a library

  • PLOS ONE (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view